{
  "id": 6315737,
  "title": "Dopamine-targeting treatments show only modest benefits for anhedonia, prompting calls for new research approaches",
  "url": "https://urgent.news/2026/09/08/dopamine-targeting-treatments-show-only-modest-benefits-for-anhedonia",
  "topic": "science",
  "section": "Science",
  "published": "2026-09-08T18:40:05.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-09-dopamine-treatments-modest-benefits-anhedonia.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "Dopamine has long been considered central to understanding anhedonia—the loss of pleasure, interest and motivation that is a common feature of depression and other mental health conditions. However, a new international expert report published in BMJ Mental Health suggests that dopamine alone cannot explain the condition and that future research must look beyond a single biological pathway.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}